Progesterone Preeclampsia
Medical University of South Carolina · NCT07448597
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 18+ · Women only
- Healthy volunteers
- Accepted
- Study type
- Interventional · Phase 4
- Target enrollment
- 642
- US sites recruiting
- 1
- Study start
- August 13, 2026
- Record last updated
- August 17, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
This randomized controlled trial evaluates whether nightly vaginal micronized progesterone (400 mg) initiated before 12 weeks' gestation reduces the incidence of preeclampsia in low-risk pregnant individuals. Participants will be randomly assigned (1:1) to receive either vaginal progesterone through 16 weeks' gestation or routine prenatal care without progesterone. Maternal and neonatal outcomes-including development of preeclampsia, obstetric complications, gestational diabetes, preterm birth, and neonatal morbidity-will be collected via chart review. The study aims to determine whether early progesterone supplementation decreases the risk of preeclampsia.
Being studied: Progesterone supplementation
Conditions: Preeclampsia; Hypertensive Disorder of Pregnancy
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- Pregnant individuals receiving prenatal care at participating clinics
- \<12 weeks gestation with a viable intrauterine pregnancy
- Age ≥18 years
- English-speaking
Exclusion Criteria
- Unable or unwilling to self-administer vaginal progesterone
- Inability or unwillingness to provide informed consent
Recruiting US locations
Medical University of South Carolina
Charleston, SC 29401
Site contact: Lauren Yacobucci, MD · 7163415115 · yacobucc@musc.edu
Similar studies in South Carolina
All pregnancy studies in South Carolina →- RecruitingHealthy volunteersPhase 3
A Phase 3 Study of Revaccination in Subsequent Pregnancies With Bivalent RSV Vaccine and Duration of Protection of a Single Dose
Pfizer
- Location
- Greenville, SC + 76 other US sites
- Eligibility basics
- Ages 0 mo+
- Recruiting
SAINT in Postpartum Depression (PPD)
Magnus Medical
- Location
- Charleston, SC + 3 other US sites
- Eligibility basics
- Ages 18–45 · Women only
- RecruitingHealthy volunteers
The Society for Obstetric Anesthesia and Perinatology Research Network General Anesthesia Registry
Yale University
- Location
- Charleston, SC + 32 other US sites
- Eligibility basics
- Ages 15–55 · Women only
- RecruitingHealthy volunteers
Blood Warming in Preterm Infants to Decrease Hypothermia
University of South Carolina
- Location
- Columbia, SC
- Eligibility basics
- Ages 6 mo–7 mo